Vascepa and Lopressor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vascepa (icosapent ethyl) and Lopressor (metoprolol tartrate). Common drug interactions include pleural effusion among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Vascepa and Lopressor. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Vascepa?

Vascepa has active ingredients of icosapent ethyl. It is often used in high blood cholesterol. eHealthMe is studying from 5,894 Vascepa users. Check the latest studies of Vascepa.

What is Lopressor?

Lopressor has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 33,152 Lopressor users. Check the latest studies of Lopressor.

On Jul, 14, 2026

22 people who take Vascepa and Lopressor together, and have interactions are studied.

Vascepa and Lopressor drug interactions.

What are the common drug interactions of Vascepa and Lopressor, by gender? *:

female:

Pleural effusion (water on the lungs)
Septic shock (shock due to blood infection)
Nausea (feeling of having an urge to vomit)
Acute respiratory distress syndrome
Acute respiratory failure
Adenovirus infection
Arthralgia (joint pain)
Blood sodium decreased
Brain natriuretic peptide increased
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)

male:

Acute respiratory failure
White blood cell count decreased
Rash pruritic (redness with itching)
Platelet count decreased
Diarrhoea
Hand-foot-and-mouth disease
Cardiac failure
Dysuria (painful or difficult urination)
Hyperkalaemia (damage to or disease of the kidney)
Pain

What are the common drug interactions of Vascepa and Lopressor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Acute respiratory failure
White blood cell count decreased
Death
Decreased appetite
Diarrhoea
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Dysuria (painful or difficult urination)
Haematocrit decreased
Haemoglobin decreased
Hyperkalaemia (damage to or disease of the kidney)

What are the existing conditions these people have? *

Insomnia (sleeplessness): 6 people, 27.27%
Type 2 Diabetes: 5 people, 22.73%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 22.73%
Constipation: 5 people, 22.73%
Diarrhea: 5 people, 22.73%
Enlarged Prostate: 5 people, 22.73%
Febrile Neutropenia (fever with reduced white blood cells): 5 people, 22.73%
Nausea (feeling of having an urge to vomit): 5 people, 22.73%
Nausea And Vomiting: 5 people, 22.73%
Pain: 5 people, 22.73%

* Approximation only. Some reports may have incomplete information.

Do you take Vascepa and Lopressor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously